Pharmacokinetics and Pharmacodynamics of Rusfertide, a Hepcidin Mimetic, Following Subcutaneous Administration of a Lyophilized Powder Formulation in Healthy Volunteers
Rusfertide was well tolerated; the pharmacokinetic and pharmacodynamic results indicate that lyophilized rusfertide is suitable for once-weekly or twice-weekly administration.
Authors
- Sneha Rudraraju
- Frank H. Valone
- Nishit B. Modi (ORCID: https://orcid.org/0000-0002-5111-867X)
- Sarita Khanna
Institutions
- Protagonist Therapeutics (United States) (US)
Publication Details
- Journal
- Drugs in R&D
- Published
- 2024-11-15
- DOI
- https://doi.org/10.1007/s40268-024-00497-z
- Citations
- 4
- Primary Topic
- Iron Metabolism and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.82